FDA DEVICE FACTS
Atlas Multi-Drugs Screening Test Cup, Atlas Multi-Drugs Screening Test Panel
Atlas Medical
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Atlas Multi-Drugs Screening Test Cup and Atlas Multi -Drugs Screening Test Panel are lateral flow chromatographic in vitro diagnostics immunoassays for the qualitative detection of following drugs in urine without the need of instruments: Drug Name Calibrator Cut-off Amphetamine (AMP) D-Amphetamine 1000 Methylenedioxymethamphetamine (MDMA) D,L Methylenedioxymethamphetamine 500 Morphine (MOP) Morphine 300 Morphine (MOP) Morphine 2000 Oxycodone (OXY) Oxycodone 100 Cocaine (COC) Benzoylecgonine 300 Nortriptyline Nortriptyline 1000 Methamphetamine (MET) D-Methamphetamine 1000 Phencyclidine (PCP) Phencyclidine 25 Marijuana (THC) 11-nor-Δ9-THC-9 COOH 50 Secobarbital Secobarbital 300 Oxazepam Oxazepam 300 Methadone (MTD) Methadone 300 Propoxyphene (PPX) Propoxyphene 300 Buprenorphine(BUP) Buprenorphine 10 The tests are intended for professional use only. The tests will yield preliminary positive results when the prescription drugs Secobarbital, oxazepam, Buprenorphine, Oxycodone, Propoxyphene, and Nortriptyline are ingested, even at or above therapeutic doses. There are no uniformly recognized drug levels for Secobarbita l, oxazepam, Buprenorphine, Oxycodone, Propoxyphene, and Nortriptyline in urine. The multi-drugs screening tests (Cup and Panel formats) show the drug was or was not present at the cutoff level. The tests provide only preliminary test results, which must b e confirmed by other methods such as gas chromatography/mass spectrometry (GC/MS). Clinical considerations and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. The tests are not intended to be used in monitoring the drug levels.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。